SOLAZYME INC COM STK (DE)
SZYM
SZYM was delisted on the 10th of May, 2016.
100 hedge funds and large institutions have $114M invested in SOLAZYME INC COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 29 reducing their positions, and 12 closing their positions.
3% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 29
1% more capital invested
Capital invested by funds: $112M → $114M (+$1.27M)
2% less funds holding
Funds holding: 102 → 100 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
94% less call options, than puts
Call options by funds: $502K | Put options by funds: $8.94M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$657K |
| 2 |
Morgan Stanley
New York
|
+$505K |
| 3 |
PC
Passport Capital
San Francisco,
California
|
+$437K |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$296K |
| 5 |
Primecap Management
Pasadena,
California
|
+$276K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$2.59M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$2.14M |
| 3 |
Goldman Sachs
New York
|
-$1.61M |
| 4 |
T
Tahithromos
New York
|
-$1.55M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$897K |
SZYM Hedge Fund Activity: Q2 2015 in Review
100 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in SOLAZYME INC COM STK (DE) (SZYM) for Q2 2015, worth a combined $114M — up 1.1% from $112M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of SZYM and 10 opened new positions — a net loss of 2 holders — while 29 trimmed existing stakes and 30 added.
The largest buyer was UBS Group, adding an estimated $657K. The largest seller was United Capital Financial Advisors, cutting an estimated $2.59M.
- 100 institutional investors held SOLAZYME INC COM STK (DE) (SZYM) as of Q2 2015, down from 102 in Q1 2015.
- Funds reported $114M of SOLAZYME INC COM STK (DE) stock for Q2 2015, up 1.1% quarter-over-quarter.
- 10 funds opened new SOLAZYME INC COM STK (DE) positions in Q2 2015 and 12 closed out, a net change of -2 holders.
- The largest SOLAZYME INC COM STK (DE) buyer in Q2 2015 was UBS Group, an estimated $657K added.
- The largest SOLAZYME INC COM STK (DE) seller in Q2 2015 was United Capital Financial Advisors, an estimated $2.59M sold.
Based on aggregated 13F filings for Q2 2015.